Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Edge To Edge Repair for the Treatment of Severe Tricuspid Valve Regurgitation in High-surgical Risk Patients With Systemic Right Ventricle : a Multicentric French Cohort.

NCT05052177 is registered in ClinicalTrials.gov with University of Bordeaux as lead sponsor.

NCT NCT05052177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Edge To Edge Repair for the Treatment of Severe Tricuspid Valve Regurgitation in High-surgical Risk Patients With Systemic Right Ventricle : a Multicentric French Cohort.
Lead sponsor
University of Bordeaux
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2020
Completion date
October 30, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, systemic right ventricle, tricuspid regurgitation